Neopenda develops a wearable neonatal vitals monitor that continuously measures pulse rate, respiratory rate, oxygen saturation and temperature and wirelessly transmits data to a tablet. The device is rechargeable, low-power and designed for settings with inconsistent electricity. Neopenda plans to begin manufacturing and commercializing the product with the new financing and to expand clinical pilots beyond its current base in Uganda. The company was founded in 2015 by Sona Shah and Teresa Cauvel and participated in the 2018 Techstars Chicago cohort. Earlier this year the startup raised about $288,000 in a crowdfunding campaign. The new funding will support commercialization and broader clinical deployment.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2019